Cowen Prime Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Cowen Prime Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,500	Closed	-$778K	–	341
2015 Q1	$778K	Buy	+4,500	New	+$661K	0.32%	49

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Cowen Prime Advisors's SLXP Position: Q2 2015 in Review

Cowen Prime Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 4,500 shares — an estimated $778K sold.

Cowen Prime Advisors first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $778K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Cowen Prime Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Cowen Prime Advisors sold 4,500 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $778K.
Cowen Prime Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Cowen Prime Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $778K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Cowen Prime Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.